MedPath

A plant based Ayurvedic medicine used for the prevention and management of various risk factors responsible for occurrence of Coronary Heart Disease.

Phase 3
Conditions
Health Condition 1: null- Coronary Heart Disease
Registration Number
CTRI/2015/01/005397
Lead Sponsor
Department of Science Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
1000
Inclusion Criteria

Diagnosed cases of CHD consenting to participate in clinical drug trial program were included in the study.

These CHD patient showing dyslipidemia, atherosclerotic, ischemic changes, elevated homocysteine and inflammatory markers, concentration with certain psychological complaints mainly sleep disturbances were treated with test formulation.

The diagnosis of CHD patients were done on the basis of clinical as well as laboratory findings.

Exclusion Criteria

Patients suffering from chronic illness like T.B., Rheumatoid arthritis, diagnosed IHD cases; Type-1 diabetic patients; Evidence of hypo or hyperthyroidism; Age above 75 years.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The test formulation has shown Cardio-protective property through its anti-atherosclerotic, anti-inflammatory, anti-obesity activityTimepoint: Parameters measured at baseline (initial), 3 months and 6 months
Secondary Outcome Measures
NameTimeMethod
The test formulation has shown reduction in anxiety level as well as improved sleep pattern among CHD patientsTimepoint: Parameters measured at baseline (initial), 3 months and 6 months
© Copyright 2025. All Rights Reserved by MedPath